Log in

NASDAQ:DRADDigirad Stock Price, Forecast & News

-0.17 (-7.62 %)
(As of 05/29/2020 04:00 PM ET)
Today's Range
Now: $2.06
50-Day Range
MA: $2.84
52-Week Range
Now: $2.06
Volume323,915 shs
Average Volume571,017 shs
Market Capitalization$4.33 million
P/E RatioN/A
Dividend YieldN/A
Digirad Corporation provides healthcare solutions in the United States and internationally. It operates through three segments: Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging. The Diagnostic Services segment provides nuclear and ultrasound imaging services to physicians who perform nuclear imaging, echocardiography, vascular or general ultrasound tests, imaging systems, radiopharmaceuticals, and licensing services. The Mobile Healthcare segment offers contract diagnostic imaging services, including computerized tomography (CT), magnetic resonance imaging, positron emission tomography (PET), PET/CT, and nuclear medicine and healthcare services to hospitals, integrated delivery networks, and federal institutions on a long-term contract basis, as well as provisional services to institutions that are in transition. The Diagnostic Imaging segment develops and sells gamma camera imaging systems, such as nuclear cardiac imaging systems and general purpose nuclear imaging systems to physician offices and hospitals; and offers camera maintenance services. Digirad Corporation was founded in 1985 and is headquartered in Suwanee, Georgia.
Read More
Digirad logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.27 out of 5 stars

Industry, Sector and Symbol

Industry Electromedical equipment
Current SymbolNASDAQ:DRAD



Sales & Book Value

Annual Sales$114.18 million
Cash Flow$3.89 per share
Book Value$8.47 per share


Net Income$-4,630,000.00


Market Cap$4.33 million
Next Earnings Date8/4/2020 (Estimated)

Receive DRAD News and Ratings via Email

Sign-up to receive the latest news and ratings for DRAD and its competitors with MarketBeat's FREE daily newsletter.

Digirad (NASDAQ:DRAD) Frequently Asked Questions

How has Digirad's stock been impacted by COVID-19 (Coronavirus)?

Digirad's stock was trading at $3.46 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, DRAD stock has decreased by 40.5% and is now trading at $2.06. View which stocks have been most impacted by Coronavirus.

When is Digirad's next earnings date?

Digirad is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Digirad.

How were Digirad's earnings last quarter?

Digirad Co. (NASDAQ:DRAD) issued its earnings results on Friday, May, 15th. The medical equipment provider reported ($0.81) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($1.05) by $0.24. The medical equipment provider earned $28.86 million during the quarter. Digirad had a negative net margin of 4.97% and a positive return on equity of 0.59%. View Digirad's earnings history.

When did Digirad's stock split? How did Digirad's stock split work?

Digirad's stock reverse split on the morning of Wednesday, June 5th 2019. The 1-10 reverse split was announced on Friday, May 31st 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, June 4th 2019. An investor that had 100 shares of Digirad stock prior to the reverse split would have 10 shares after the split.

What guidance has Digirad issued on next quarter's earnings?

Digirad updated its FY 2020 Pre-Market earnings guidance on Friday, March, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $125-145 million.

Has Digirad been receiving favorable news coverage?

Headlines about DRAD stock have trended very negative on Saturday, InfoTrie Sentiment reports. The research firm scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Digirad earned a daily sentiment score of -3.5 on InfoTrie's scale. They also gave press coverage about the medical equipment provider a news buzz of 9.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days. View the latest news aboutDigirad.

Are investors shorting Digirad?

Digirad saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 76,000 shares, an increase of 97.9% from the April 30th total of 38,400 shares. Based on an average trading volume of 267,400 shares, the short-interest ratio is currently 0.3 days. Approximately 4.1% of the shares of the stock are short sold. View Digirad's Current Options Chain.

Who are some of Digirad's key competitors?

What other stocks do shareholders of Digirad own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Digirad investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), AT&T (T), AbbVie (ABBV), Exelixis (EXEL), Cronos Group (CRON), General Electric (GE), Novavax (NVAX), Pfizer (PFE) and Rigel Pharmaceuticals (RIGL).

Who are Digirad's key executives?

Digirad's management team includes the following people:
  • Mr. Matthew Gabel Molchan, Pres, CEO & Director (Age 52)
  • Mr. Martin B. Shirley, Pres of Digirad Imaging Solutions (Age 57)
  • Mr. David James Noble, COO & Interim CFO (Age 48)
  • Mr. Bob Halbert, Sr. Director of Human Resource

What is Digirad's stock symbol?

Digirad trades on the NASDAQ under the ticker symbol "DRAD."

How do I buy shares of Digirad?

Shares of DRAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Digirad's stock price today?

One share of DRAD stock can currently be purchased for approximately $2.06.

How big of a company is Digirad?

Digirad has a market capitalization of $4.33 million and generates $114.18 million in revenue each year. Digirad employs 452 workers across the globe.

What is Digirad's official website?

The official website for Digirad is www.digirad.com.

How can I contact Digirad?

Digirad's mailing address is 1048 INDUSTRIAL COURT, SUWANEE GA, 30024. The medical equipment provider can be reached via phone at 858-726-1600 or via email at ir.digirad.com.

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.